AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2013
Apr 1, 2013
33422_dirs_2013-04-01_68054d6a-074e-4b22-84ae-bf2eedec48f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-03-28
Reporting Person: Prelack Steven (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-28 | Stock Option (right to buy) | $3.59 | A | 16714 | Acquired | 2023-03-28 | Common Stock (16714) | Direct |
Footnotes
F1: The option vests quarterly in eight equal installments beginning on May 12, 2013.
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21